We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
ARIAD Pharmaceuticals has entered into nonexclusive agreements with Medinol
to develop and commercialize stents and other medical devices to deliver ARIAD's
mTOR inhibitor, AP23573, to prevent reblockage of injured vessels following
stent-assisted angioplasty.
Edwards Lifesciences is realigning its business in Japan as part of the company's
continued efforts to focus on its core cardiovascular businesses as it transforms
into a faster-growing, more profitable company.
TranS1, a medical device firm focused on developing minimally invasive product
solutions for the treatment of lower back pain, has announced the U.S. market
release of its Axial Lumbar Interbody Fusion (AxiaLIF) System.
Thoratec commented on its investigational device exemption (IDE) application
to the FDA to conduct a Phase II pivotal clinical trial for the company's HeartMate
II.
Avanca Medical Devices, a private company spun from
the University of New Mexico in March of last year, has received approval from
the FDA to market two versions of its reciprocating syringe.
MedX Health, developer, manufacturer and distributor of innovative phototherapy
devices, has announced a partnership with Extendicare Health Services nursing
facilities in Ohio to enhance rehabilitation treatment and quality of care for
patients.
Thermage, a medical device company that manufactures and markets noninvasive
treatments to tighten and contour skin, named Stephen Fanning as its new president
and CEO.
Chembio Diagnostics, a developer and manufacturer of rapid tests for HIV and
other infectious diseases, has launched its third HIV rapid test, HIV Stat-Pak
Dipstick, to complete its unique suite of three rapid HIV tests for use in HIV
testing programs in international settings.
iCAD, which designs, develops and markets Computer Aided Detection (CAD) imaging
technology and systems for the early detection of breast cancer and other medical
applications, has released its Second Look 700 CAD solution.
IMI International Medical Innovations has announced that PREVU Point of Care
Skin Sterol Test, a noninvasive, predictive test for coronary artery disease,
is now available for sale in Canada and the U.S. PREVU, which measures the amount
of cholesterol, or sterol, accumulated in the skin tissues, is marketed and
distributed worldwide by McNeil Consumer Healthcare.